A medical device company can have deep clinical and scientific expertise and still leave its commercial team uncertain about what to say in a customer conversation.
The expertise may sit with Medical Affairs, Scientific Affairs, clinicians, or the people who developed the product. Commercial employees and distributor partners need a reliable way to learn from it, use approved information appropriately, and recognize when a question belongs with an expert.
That translation is part of commercial readiness. It requires more than sending a technical presentation to the field.
Build the education with the experts
Clinical and scientific colleagues establish the accuracy and boundaries of product education. Commercial leadership brings the questions people hear in the field and the situations they must be prepared to navigate. Training connects the two: it organizes approved information around the decisions, conversations, and responsibilities of each role.
For example, a commercial representative should be able to explain the product using approved materials, understand the clinical context relevant to the role, and know when a question requires Medical Affairs or another qualified expert. A distributor partner needs those same boundaries, along with a dependable route to current information across markets.
Make approved knowledge usable
A strong education system helps people find the right resource at the point of need. It identifies who owns the content, how updates reach employees and partners, and what happens when a customer asks something the available material does not address.
Practice matters here. In realistic scenarios, learners can show whether they can explain approved information clearly, avoid extending a claim beyond its support, and bring in an expert when appropriate. The aim is informed judgment within defined boundaries.
Keep the field connected to the source
Customer questions change as a product reaches new people and markets. A support channel lets the field obtain an approved response and helps clinical and scientific teams see which questions recur. Those patterns can inform updates to onboarding, field tools, and ongoing education.
Leaders should ask whether clinical knowledge is available in a form their commercial teams can use consistently. If the answer depends on knowing one person or finding an old slide deck, the company has a commercial readiness gap even when its underlying expertise is strong.
Commercial readiness grows when clinical and scientific expertise is translated into approved education, practiced in context, and supported after onboarding. That work helps people represent the product with confidence and appropriate judgment.
If your company is scaling its commercial team or distributor network, email me at kelly@kellyelliottglobaladvisors.com to discuss a Commercial Readiness Strategy Session.